A complete application in a minute
Tailored resume and cover letter, ready to send.
Cytokinetics, Inc. in Radnor, PA, is seeking a Director Regulatory Affairs, Advertising and Promotion to lead US promotional material reviews, ensure FDA labeling support, and shape regulatory strategy across marketing, medical, and legal teams.
This role requires at least 10 years in pharmaceutical/biotech regulatory affairs with 7 years in U.S. advertising and promotion, a strong track record of launches, and proficiency with PromoMats; hybrid work arrangement with competitive compensation and
Cytokinetics is a specialty cardiovascular biopharmaceutical company, building on its over 25 years of pioneering scientific innovations in muscle biology, and advancing a pipeline of potential new medicines for patients suffering from diseases of cardiac muscle dysfunction.
Director Regulatory Affairs, Advertising and Promotion
Pay Range: The expected salary range for this position based on the primary location of Radnor, PA is $213,390-$248,955. The base pay offered will take into account internal equity and may vary depending on the candidate's geographic region, job‑related knowledge, skills, and experience among other factors. Base salary is just one component of our competitive total compensation package, which includes equity in the form of stock options and/or restricted stock units.
#LI-HYBRID
We are looking for the best candidates for our open roles, but do not expect applicants to meet every qualification in order to be considered.
Our passion is anchored in robust scientific thinking, grounded in integrity and critical thinking. We keep the patient front and center in all we do – all actions and decisions are in service of the patient and their caregivers. We champion integrity, ethics, doing the right thing, and being our best selves.
Cytokinetics is an Equal Opportunity Employer
Cytokinetics is a specialty cardiovascular biopharmaceutical company, building on its over 25 years of pioneering scientific innovations in muscle biology, and advancing a pipeline of potential new medicines for patients suffering from diseases of cardiac muscle dysfunction.